This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc., a subsidiary of the global healthcare leader Novartis AG, is headquartered in Canada and operates extensively across the country. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies in areas such as oncology, cardiology, and immunology. With a commitment to research and development, Novartis Canada has introduced several groundbreaking treatments that address unmet medical needs, setting them apart in a competitive market. Their portfolio includes unique biologics and targeted therapies that have significantly improved patient outcomes. Recognised for its contributions to healthcare, Novartis holds a strong market position, consistently ranking among the top pharmaceutical companies in Canada.
DitchCarbon Score
How does Novartis Pharmaceuticals Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharmaceuticals Canada Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharmaceuticals Canada Inc. currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. However, the company is part of a broader corporate family that includes Novartis AG, which has established significant climate commitments and initiatives. As a current subsidiary of Novartis AG, Novartis Pharmaceuticals Canada Inc. inherits various sustainability targets and initiatives from its parent company. Novartis AG has set ambitious science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets encompass Scope 1, 2, and 3 emissions, reflecting a comprehensive approach to climate action. While specific reduction targets for Novartis Pharmaceuticals Canada Inc. are not detailed, the overarching commitments from Novartis AG include participation in initiatives such as the Carbon Disclosure Project (CDP), RE100, and the Race to Zero campaign. These initiatives underscore the company's dedication to achieving net-zero emissions and enhancing sustainability practices across its global operations. In summary, while Novartis Pharmaceuticals Canada Inc. does not report specific emissions data, it aligns with the climate commitments and reduction initiatives set forth by Novartis AG, demonstrating a commitment to addressing climate change within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 583,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 922,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novartis Pharmaceuticals Canada Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
